• BX Home
  • Business of Biotechnology: [Page 7]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,248 news and 4,696 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

Biotech Boom Drives Lyophilisation by Andrea Charlesmore

Biological shift A growing biotechnology pipeline is fuelling the demand for lyophilisation technologies, and drug...

While Street Sleeps, Amgen Stirs Interestmore

Here's why the biotech giant is looking perky.

Penny Stock DD | Penny Stock Picks & Alerts ...more

Ethical and Scientific Implications of the Globalization of Clinical ...more

Pharmaceutical and device companies have embraced globalization as a core component of their business models,...

Investorideas.com - NASDAQ Biotech Market Gainers; (NASDAQ:BPAX), (NAS...more

Investorideas.com - Biotech Stocks on the Move: High Volume Traders; (...more

Drugmakers May Fund Ad Campaign on Health Overhaulmore

Drugmakers may push for an overhaul of the U.S. health care system by spending $100 million on ads starting as early as...

Sam Waksal's a Man About Townmore

The ImClone ex-con is free again, and he's unrepentant.

Pharmaceutical Firms Make Immunogenicity a Prioritymore

Interest in immunogenicity is growing among pharmaceutical companies. The concept - which measures the potential for a...

Old Commercial Values No Longer Enough by John Fergusonmore

As a European, I found it difficult to understand the fervour created by President Obama's health reforms.

Singularity University Gives Execs a View of the Futuremore

In his various roles as a computer programmer, an emergency-medicine physician, and the director of Microsoft (MSFT)...

Cash-Poor Biotech Firms Cut Researchmore

The credit crisis is hitting biotech hard, limiting access to bank loans and alternative financing vehicles.

Targeting New Markets to Improve Pharma Sales Force Effectivenessmore

Sales force effectiveness is highly important for companies within the pharmaceutical industry. Current economic...

Accelerating Early Stage Drug Discovery with PAM by Bryan C. Webbmore

In order to accelerate drug discovery, many labs are increasingly looking to the use of predictive modeling and...

New Genome Study Sheds Light on Biopatents by Pharma IQmore

For pharmaceutical companies, the development of effective and binding patents is often key to their efforts to...

Penny Stock DD | Penny Stock Picks & Alerts ...more

Donating Embryos for Research a Strugglemore

Between paperwork, consent forms and finding a willing recipient, donating embryos is a chore.

J&J Drug for Psoriasis Approvedmore

A new way of attacking the painful skin disease had received the green light from the FDA.

Using Software to Boost Clinical Trial Designmore

When considering the key challenges that new drugs face on their route to widespread use, clinical trials are...

Meatloaf From a Petri Dish Is Innovator’s Goal for the Massesmore

Jason G. Matheny wants to take a single stem cell and make meatloaf.

Amgen Drug Becomes First Biologic for Primary Care (Update3)more

Amgen Inc.’s bone-strengthening injection denosumab, for postmenopausal women with osteoporosis, will be the first...

The Most Expensive Drugs Are Getting Even More Expensivemore

Specialty drugs often sold by biotech companies, and used to treat complex conditions such as cancer are some of the...

Do Electronic (eCTD) Submissions Save Pharmaceutical Companies Time? 6...more

In a recent survey, Pharma IQ asked members of the pharmaceutical industry if electronic submissions were in fact...

India Looks to a Future in Clinical Trials by Pharma IQmore

If the recent recession highlighted anything to firms in all sectors, it was how important it is for them to focus on...

Top Science Policy Stories of 2008more

From biofuel to genetic discrimination, it's all summarized here....

Topic Feed: Most active content in Business of Biotechnology

Top Sources: Business of Biotechnology

  • investorideas.com
  • bioedgeconsulting.com
  • Biotech Blog
  • bloomberg.com
  • youtube.com
  • News
  • contrarianprofits.com
  • Forbes.com
  • industry.bnet.com
  • Health Beat

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
Chief Medical Officer (CMO) for Pharma/Biotech Epc Search International | North Carolina
Posted: Apr 18

Report comment contains invalid characters. ()
cancel
Search Cancel